PEMETREXED FRESENIUS KABI 25mg/ml concentrate for solution for infusion
pemetrexeda Indicated for: non-small cell lung cancer
L01BA04 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
letter P · page 22
pemetrexeda Indicated for: non-small cell lung cancer
L01BA04 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
pemetrexeda Indicated for: non-small cell lung cancer
L01BA04 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
pemetrexeda Indicated for: non-small cell lung cancer
L01BA04 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
pemetrexeda Indicated for: non-small cell lung cancer
L01BA04 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
pemetrexeda Indicated for: non-small cell lung cancer
L01BA04 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
pemetrexeda Indicated for: non-small cell lung cancer
L01BA04 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
pemetrexeda Indicated for: non-small cell lung cancer
L01BA04 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
pemetrexeda Indicated for: non-small cell lung cancer
L01BA04 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
pemetrexeda Indicated for: non-small cell lung cancer
L01BA04 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
pemetrexeda Indicated for: non-small cell lung cancer
L01BA04 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
pemetrexeda Indicated for: non-small cell lung cancer
L01BA04 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
pemetrexeda Indicated for: non-small cell lung cancer
L01BA04 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
pemetrexeda Indicated for: non-small cell lung cancer
L01BA04 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
pemetrexeda Indicated for: non-small cell lung cancer
L01BA04 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
pemetrexeda Indicated for: non-small cell lung cancer
L01BA04 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
pemetrexeda Indicated for: non-small cell lung cancer
L01BA04 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
pemetrexeda Indicated for: non-small cell lung cancer
L01BA04 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
pemetrexeda Indicated for: non-small cell lung cancer
L01BA04 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
pemetrexeda Indicated for: non-small cell lung cancer
L01BA04 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues
pemetrexeda Indicated for: non-small cell lung cancer
L01BA04 Antineoplastic and immunomodulating agents | Antimetabolites | Folic acid analogues